Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Repeated-Dose Evaluation of Use of a Pain Relieving Drug and Safety of OROS Hydromorphone HCI in Patients With Chronic Cancer Pain

This study has been completed.
Information provided by:
Alza Corporation, DE, USA Identifier:
First received: December 12, 2006
Last updated: April 26, 2010
Last verified: April 2010
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 1999
  Estimated Primary Completion Date: No date given